芳香化酶抑制剂手术前治疗绝经后乳腺癌的疗效观察
被引量:6
摘要
乳腺癌是女性常见恶性肿瘤,其发病率呈上升趋势。据1998年—2002年期间全国肿瘤登记中心统计,乳腺癌发病率已位居我国女性恶性肿瘤的首位。自Beatson应用卵巢切除术治疗局部晚期乳腺癌至今,乳腺癌的内分泌治疗已有超过百年的历史。
出处
《中国癌症杂志》
CAS
CSCD
北大核心
2010年第3期239-240,共2页
China Oncology
基金
北京市科技计划课题(编号:D0905001040131)
参考文献14
-
1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
-
2Beatson GT.On the treatment of inoperable cases of carcinoma of the mamma:suggestions for a new method of treatment,with illustrative cases[J].Lancet,1896,2:104-107.
-
3Gazet JC,Ford HT,Coomhes RC,et al.Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer[J].Eur J Surg Oncol,1994,20(3):207-214.
-
4Gazer JC,Markopoulos C,Ford HT,et al.Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer[J].Lancet,1988,1(8587):679-681.
-
5Fennessy M,Bates T.MacRae K,et al.Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer[J].Br J Surg,2004,91(6):699-704.
-
6Smith IE,Dowsett M,Ebbs SR,et al.Neoadjuvant treatment of postmenopausal breast cancer with anastrozole,tamoxifen,or both in combination:the immediate preoperative anastrozole.tamoxifen,or combined with tamoxifen(IMPACT)multicenter double-blind randomized trial[J].J Clin Oncol,2005,23(22):5108-5016.
-
7Ellis MJ,Tao Y,Luo J,et al.Outcome prediction for estrogen receptor-positive breast cancer based on post neoadjuvant endocrine therapy tumor characteristics[J].J Natl Cancer Inst,2008,100(19):1380-1388.
-
8Ellis MJ,Coop A,Singh B,et al.Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1-and/or ErbB-2-positive,estrogen receptor-positive primary breast cancer:evidence from a phase Ⅲ randomized trial[J].J Clin Oncol,2001,19(18):3808-3816.
-
9Kaufmann M,Hortobagyi GN,Goldhi rsch A,et al.Recommendations from an international expert panel on the use of neoadjuvant(primary)systemic treatment of operable breast cancer:an update[J].J Clin Oncol,2006,24(12):1940-1949.
-
10Paepke S,Tulusan A,Kiesel L,et al.A multi-center study of pre-operative treatment with letrozole for optimal duration of treatment in postmenopausal women with ER and/or PGR positive breast cancer[J].Proc Am Soc Clin Oncol,2003,22:321.
二级参考文献77
-
1张保宁,邵志敏,乔新民,李波,姜军,杨名添,王水,宋三泰,张斌,杨红健.中国乳腺癌保乳治疗的前瞻性多中心研究[J].中华肿瘤杂志,2005,27(11):680-684. 被引量:247
-
2张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
-
3[1]Parkin D M,Bray F,Ferlay J,et al.Global cancer statistics,2002.CA Cancer J Clin,2005,55:74-108.
-
4[2]Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008.CA Cancer J Clin,2008,58:71-96.
-
5[4]Early Breast Cancer Trialists' Collaborative Group (EBCTCG).Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:an overview of the randomised trials.Lancet,2005,365:1687-1717.
-
6[5]Arriagada R,Lê MG,Rochard F,et al.Conservative treatment versus mastectomy in early breast cancer:patterns of failure with 15 years of follow-up data.Institut Gustave-Roussy Breast Cancer Group.J Clin Oncol,1996,14:1558-1564.
-
7[6]Early Breast Cancer Trialists' Collaborative Group.Effects of radiotherapy and surgery in early breast cancer:an overview of the randomized trials.N Engl J Med,1995,333:1444-1455.
-
8[7]Fisher B,Anderson S,Bryant J,et al.Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med,2002,347:1233-1241.
-
9[8]Veronesi U,Cascinelli N,Mariani L,et al.Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.N Engl J Med,2002,347:1227-1232.
-
10[9]Abrams J S,Philips P H,Friedman M A.Meeting highlights:a reappraisal of research results for the local treatment of early stage breast cancer.J Natl Cancer Inst,1995,87:1837-1845.
共引文献174
-
1李光春,刘文,林敏,金东晖,陈桂株,刘加吾,刘慧林,李益德,甘邵安,谭明阳,肖佑池.湖南省居民慢性非传染性疾病流行现况的调查分析[J].实用预防医学,2006,13(6):1483-1485. 被引量:12
-
2胡德胜,谭文勇,魏来.结直肠癌的辅助治疗[J].肿瘤防治研究,2008,35(S1):44-46. 被引量:1
-
3陈王洋,何慧,宋冰冰,吴树岭,林英姬,戴旭东.2005年哈尔滨市南岗区居民恶性肿瘤发病与死亡分析[J].中国肿瘤,2009,18(11):890-892.
-
4樊佳奇,田锋.以表皮生长因子受体为靶点的食管鳞癌分子靶向治疗的研究进展[J].中华临床医师杂志(电子版),2012,6(20):136-138. 被引量:1
-
5华召来,郭国平,姚伟,冷荣柏,周琴.扬中市人民医院住院肿瘤患者构成特点及变化趋势[J].中国医药指南,2008,6(23):15-17.
-
6孙桢,夏庆华.肾癌不同病理亚型的MRI特点[J].泌尿外科杂志(电子版),2014,6(2):29-32. 被引量:5
-
7宗旭余,胡永勤,王来根.余杭区恶性肿瘤发病与死亡趋势分析[J].浙江预防医学,2013,25(5):44-45. 被引量:2
-
8史建伟,于跃明,王士杰,王小玲,张娟,王贵英.细丝蛋白A和基质金属蛋白酶9在结直肠腺癌中的表达及意义[J].肿瘤,2010,30(9):768-773. 被引量:11
-
9陈万青,张思维,李连弟,鲁凤珠,赵平,邹小农,陈永红.中国部分市县1998~2002年肺癌的发病与死亡[J].中国肿瘤,2006,15(9):570-574. 被引量:99
-
10邹小农,陈万青,张思维,李连弟,鲁凤珠,陈永红,赵平.中国部分市县1998~2002年食管癌发病与死亡[J].中国肿瘤,2007,16(3):142-146. 被引量:53
同被引文献33
-
1陈伟财,何劲松,王敏,吴恢升,王先明.老年乳腺癌患者新辅助内分泌治疗的临床应用[J].中国癌症杂志,2011,21(5):359-362. 被引量:23
-
2沈镇宙,柳光宇,苏逢锡,何萍青,杨名添,施俊义,盛援,邹强,李亚芬.多西紫杉醇加表柔比星治疗局部晚期乳腺癌的多中心Ⅱ期临床研究[J].中华肿瘤杂志,2005,27(2):126-128. 被引量:56
-
3刘颖,肖艳.红豆杉及其紫杉醇研究开发进展[J].中医药信息,2005,22(4):34-35. 被引量:20
-
4吴炅,范江,陆劲松,狄根红,柳光宇,陈灿铭,侯意枫,胡震,张家新,王磊,王杰,韩企夏,沈坤炜,沈镇宙,邵志敏.234例早期乳腺癌保乳治疗疗效的临床分析[J].中国癌症杂志,2006,16(9):697-700. 被引量:21
-
5马特,李爽,张强,赵林,龙飞,张斌.绝经后乳腺癌新辅助内分泌治疗近期疗效观察[J].中国肿瘤临床,2007,34(12):706-708. 被引量:10
-
6Therasse P, Arbuek SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Nal Cancer Inst,2000,92 ( 1 ) :205-216.
-
7Ellis M J, Coop A, Singh B, et al. Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status. Cancer Res,2003,63 (19) :6523-6524.
-
8Mouridsen H, Gershanovich M, Sun Y, et al. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal-women with advanced breast cancer : results of a phase Ⅲ study of the international letrozole breast cancer group. Clin Oncol,2001, 19(10) :2596-2606.
-
9刘慧,张恒伟,崔树德.新辅助化疗在乳腺癌保乳手术中的应用分析[J].中国误诊学杂志,2007,7(21):4981-4982. 被引量:6
-
10Mouridsen,H,Gershanovich,M,Sun,Y,Perez-Carrion,R,Boni,C,Monnier,A,Apffelstaedt,J,Smith,R,Sleeboom,HP,Janicke,F,Pluzanska,A,Dank,M,Becquart,D,Bapsy,PP,Salminen,E,Snyder,R,Lassus,M,Verbeek,JA,Staffler,B,Chaudri-Ross,HA,Dugan,M.Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. Journal of Clinical Oncology . 2001
引证文献6
-
1陈伟财,何劲松,王敏,吴恢升,王先明.老年乳腺癌患者新辅助内分泌治疗的临床应用[J].中国癌症杂志,2011,21(5):359-362. 被引量:23
-
2姚慧韬,吴康康.来曲唑用于绝经后乳腺癌手术前治疗的临床研究[J].中国基层医药,2012,19(3):395-396. 被引量:6
-
3李雪莹.新辅助内分泌治疗老年乳腺癌患者的临床效果观察[J].中国卫生标准管理,2016,7(10):57-58. 被引量:2
-
4李长春.他莫昔芬对绝经后三阴性乳腺癌根治术后患者生存期及生活质量的分析[J].实用妇科内分泌电子杂志,2016,3(18):94-95. 被引量:1
-
5史昌存.TE、TEC及紫杉醇周方案新辅助化疗在乳腺癌治疗中的对比[J].中国继续医学教育,2018,10(6):128-130.
-
6陈铃丽,黄向华,王健,李兴慧,褚飞虎,陈晓燕.绝经后乳腺癌64例新辅助内分泌治疗临床分析[J].南通大学学报(医学版),2017,37(5):481-483.
二级引证文献31
-
1陈伟财,王敏,吴恢升,何劲松,王先明.新辅助化疗联合曲妥珠单抗对HER-2过表达乳腺癌的疗效观察[J].中国普通外科杂志,2012,21(5):503-507. 被引量:5
-
2程林.来曲唑在绝经后乳腺癌新辅助内分泌治疗中的疗效及安全性观察[J].中国医药指南,2012,10(27):482-482. 被引量:6
-
3陈伟财,何劲松,吴恢升,王敏,宋淑芬,王先明.乳腺癌分子生物学指标的表达及与临床病理特征分析[J].山西医科大学学报,2013,44(1):9-12. 被引量:5
-
4朱丽娟.绝经前后的乳腺癌患者血清生殖激素的分布情况分析[J].中国综合临床,2013,29(5):461-463. 被引量:2
-
5黄文河,吴俊东,张国君,吴碧娟,陈明,黄子一,杜彩文.不可手术局部晚期乳腺癌的多学科综合治疗[J].西部医学,2013,25(5):660-662. 被引量:2
-
6李丽霞,胡文铧,刘广雁,张英.EGFR、ER、E-Cadherin在乳腺癌中的表达及其临床意义[J].中国现代医生,2013,51(20):30-31. 被引量:2
-
7王丽娟,张颖超,徐景伟.老年和青年乳腺癌的分子分型与淋巴结转移的对比[J].中国老年学杂志,2013,33(15):3771-3772. 被引量:5
-
8马传栋,严伟国,丁涵之,全红,韩晶.老年局部晚期乳腺癌新辅助化疗的疗效分析[J].中国医药指南,2013,11(25):5-7. 被引量:1
-
9陈伟财,何劲松,吴恢升,王敏,宋淑芬,王先明.TCH与TAC新辅助化疗在HER-2过表达乳腺癌中的疗效观察[J].中国肿瘤临床,2014,41(6):373-376. 被引量:17
-
10张厚云,赵凌云.乳腺癌内分泌治疗研究进展[J].中国普通外科杂志,2014,23(5):680-684. 被引量:28
-
1程林.来曲唑在绝经后乳腺癌新辅助内分泌治疗中的疗效及安全性观察[J].中国医药指南,2012,10(27):482-482. 被引量:6
-
2杨晓东,李雅华,张丽莉.复发性卵巢癌的综合治疗[J].中国肿瘤临床与康复,2007,14(2):173-177. 被引量:8
-
3何爱琴.肿瘤细胞减灭术后紫杉醇联合卡铂治疗原发性输卵管癌24例[J].交通医学,2010,24(6):692-693. 被引量:3
-
4刘秀清,陈延条,满运艳,王仁本,韩庆俊.髓母细胞瘤术后放射治疗40例临床分析[J].中华放射肿瘤学杂志,1990,0(1):61-61. 被引量:2
-
5朱悦茗,李丹,吴学勇.乳腺癌内分泌治疗研究进展[J].上海医药,2012,33(18):9-13. 被引量:8
-
6龚益平,原俊,赵德绵.芳香化酶抑制剂治疗乳腺癌研究进展[J].中国肿瘤,2001,10(12):734-736. 被引量:5
-
7Cowe.,JK,邓应平.百年来视网膜母细胞瘤的研究:临床—基因—临床[J].眼底病,1990,6(2):124-125.
-
8李荣萍,任佳,吕文静,张立娜,刘峰.来曲唑在绝经后乳腺癌新辅助内分泌治疗中的应用[J].山东医药,2009,49(32):67-69. 被引量:8
-
9谢晖.乳腺癌的内分泌治疗[J].辽宁中医学院学报,2005,7(4):349-349. 被引量:1
-
10王利霞,施红旗,朱寿田.新辅助内分泌治疗在绝经后乳腺癌中的应用[J].实用肿瘤学杂志,2008,22(3):259-260. 被引量:6